Jordan U. Gutterman
Impact in
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 81
- Chronic Myeloid Leukemia Treatments 40
- Acute Myeloid Leukemia Research 29
- Immunology 97
- Immunotherapy and Immune Responses 47
- Immune Cell Function and Interaction 31
- Co-authors
- Moshe TalpazRazelle KurzrockJorge R. QuesadaEvan M. HershJosé M. TrujilloHagop M. KantarjianGiora M. MavligitKenneth B. McCredie
- Journals
- Cancer (32 papers)JNCI Journal of the National Cancer Institute (9 papers)Journal of Clinical Oncology (9 papers)Cancer Immunology Immunotherapy (9 papers)Proceedings of the National Academy of Sciences (8 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Jordan U. Gutterman
308 papers receiving 15.1k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Hematology 4.0k
- Genetics 2.9k
- Immunology 4.5k
- Oncology 5.4k
- Pathology and Forensic Medicine 1.8k
Countries citing papers authored by Jordan U. Gutterman
This map shows the geographic impact of Jordan U. Gutterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordan U. Gutterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordan U. Gutterman more than expected).
Fields of papers citing papers by Jordan U. Gutterman
This network shows the impact of papers produced by Jordan U. Gutterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordan U. Gutterman. The network helps show where Jordan U. Gutterman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jordan U. Gutterman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis Hit paper breakdown → | 2007 | 712 |
| 2 | 2004 | 65 | |
| 3 | 2004 | 69 | |
| 4 | Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture. | 1997 | 10 |
| 5 | Biological response modifiers in the treatment of hematopoietic neoplasia | 1992 | 4 |
| 6 | Biologic therapy of human cancer. | 1992 | 2 |
| 7 | Treatment of acute myelogenous leukemia with chemotherapy and hematopoietic growth factors | 1990 | 2 |
| 8 | Novel therapeutic approaches for chronic myelogenous leukemia | 1990 | 2 |
| 9 | 1989 | 23 | |
| 10 | 1989 | 21 | |
| 11 | Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor gene. | 1988 | 15 |
| 12 | 1987 | 18 | |
| 13 | 1985 | 1 | |
| 14 | 1984 | 5 | |
| 15 | Renal cell carcinoma: antitumor effects of leukocyte interferon. | 1983 | 248 |
| 16 | 1982 | 35 | |
| 17 | Phase I study of MVE-2 therapy in human cancer | 1981 | 2 |
| 18 | Some host defense modifying effects of intravenous microbial adjuvants | 1979 | 1 |
| 19 | Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative. | 1978 | 63 |
| 20 | New agents and combination chemotherapy of non-Hodgkin's lymphoma. | 1975 | 9 |
About Jordan U. Gutterman
Jordan U. Gutterman is a scholar working on Hematology, Immunology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 312 papers that have together received 16.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (47 papers), Chronic Myeloid Leukemia Treatments (40 papers), Chronic Lymphocytic Leukemia Research (39 papers), Immune Cell Function and Interaction (31 papers), Acute Myeloid Leukemia Research (29 papers), Cancer Immunotherapy and Biomarkers (28 papers), Neutropenia and Cancer Infections (24 papers) and Lymphoma Diagnosis and Treatment (23 papers). The work is most often cited by research in Hematology (4.0k citations), Genetics (2.9k citations), Immunology (4.5k citations), Oncology (5.4k citations) and Pathology and Forensic Medicine (1.8k citations). Jordan U. Gutterman has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Moshe Talpaz, Razelle Kurzrock, Jorge R. Quesada, Evan M. Hersh, José M. Trujillo, Hagop M. Kantarjian, Giora M. Mavligit, Kenneth B. McCredie, E. M. Hersh and Mark Blick. Their work appears in journals such as Cancer, JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology, Cancer Immunology Immunotherapy and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.